Jan-Mar 2018
Inglese
The use of drugs in pregnancy is a debated and extremely interesting topic for a series of reasons. Since the Sixties, when the thalidomide tragedy occurred, healthcare professionals have been more and more careful in prescribing drugs during pregnancy. On the other hand, however, the increased availability of over-the-counter products, self-prescription, the availability of new molecules on the market and the increase of pregnant women with chronic diseases has determined a wide exposure to drugs during pregnancy.1
Thanks to the global access to information on the Internet, patients have become more and more critic and sometimes worried about the potential adverse reactions to drugs. This situation has enhanced the necessity for their doctors and other health professionals to update their knowledge on pharmacovigilance.
From Veterinary to humans
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti informazioni sul potenziale rischio di errore terapeutico legato alla nuova formulazione di Noradrenalina Tartrato Aguettant 0,5 MG/ML soluzione per infusione, in flaconcino da 50 ml.
Me lo ricordo bene quell'anziano professore che fu ricoverato nell'autunno del 2004 nel reparto di Medicina. Una persona tranquilla e gentile, silenziosa, sempre con un libro in mano. Da qualche anno gli era stata diagnosticata un'artrite reumatoide e da due settimane era stato messo in terapia con metotrexato, una compressa da 2,5 mg ogni 7 giorni.
80.211.154.110